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The inhibitory co-receptor programmed death 1 (PD-1, encoded by pdcd1) and its two ligands PD-L1 and PD-L2 comprise an 
important immune inhibitory signaling pathway for defense against microbes and for self-tolerance. Unlike other members of 
the B7-CD28 family, expression of PD-L1 and PD-L2 is not limited to the immune system. In this study, we determined that a 
polyclonal antibody (pAb) (R&D Systems) against extracellular domains of mouse PD-L2 (mPD-L2) could recognize anti-
gen(s) in diverse mouse tissues, including the anterior and intermediate pituitary gland, olfactory bulbs and olfactory epitheli-
um, tongue epithelium, keratinized epithelial cells and skin and whisker hair follicles. These findings differed from previous 
reports of mPD-L2 localization. Reverse transcription PCR and Western blot analyses, however, were unable to detect any 
mPD-L2 transcripts or proteins of the 25-kD predicted molecular weight in RNA and protein extracts, respectively, from the 
above tissues, suggesting that the anti-mPD-L2 pAb cross-reacts with certain novel antigen(s). Developmental studies revealed 
that the earliest expression of mPD-L2-like antigen was in the olfactory epithelium at embryonic day 12.5 (E12.5). At E14.5, 
mPD-L2-like antigen was present in the skin, tongue and follicles of the skin and whiskers. The distribution patterns of 
mPD-L2-like antigen remained similar from E18.5 to adulthood. The results of bioinformatic analysis and other experiments 
suggested neural cell adhesion molecule and hemicentin-1 as candidate proteins with cross-reactivity to the anti-mPD-L2 pAb. 
These results demonstrate that care is required in interpreting staining patterns generated when anti-PD-L2 pAb is used to lo-
cate PD-L2-expressing cells in the central nervous system and epithelial tissues, such as the olfactory epithelium. In addition, 
this anti-PD-L2 pAb may be used as an alternative antibody for labeling the olfactory epithelium during embryonic develop-
ment in mice. 
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Signaling pathways involving the B7-CD28 family critically 
regulate the balance between the stimulatory and inhibitory 
signals needed for defense against microbes and for 
self-tolerance. These pathways provide secondary signals 
that can regulate the activation, inhibition, and fine-tuning 
of T-cell responses [1,2]. The programmed death-1 (PD-1)/    
PD-ligands pathway is one of the B7-CD28 pathways, 
comprising the PD-1 receptor and its two ligands, PD-L1 
(also known as B7-H1 or CD274) and PD-L2 (also known 
as B7-DC or CD273). PD-1 belongs to the CD28 family and 
shares 23% amino acid sequence homology with cytotoxic 
T-lymphocyte-associated antigen 4 (CTLA-4) [2,3]. The 
extracellular region of PD-1 consists of a single IgV-like 
domain and its cytoplasmic region contains an immunore-
ceptor tyrosine-based inhibitory motif and an immunore-
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ceptor tyrosine-based switch motif. PD-1 is inducibly ex-
pressed on activated T cells, B cells and myeloid cells. 
PD-L1 and PD-L2 are type I transmembrane proteins with 
immunoglobulin (Ig)V- and IgC-like domains in the extra-
cellular region. PD-L1 is constitutively expressed in T cells, 
B cells, macrophages and dendritic cells. The expression of 
PD-L1 is also detected on non-lymphoid cells, such as en-
dothelial cells in the heart, β cells in the pancreas, glial cells 
in the inflamed brain and muscle cells [4–6], as well as in 
ovary, esophagus, kidney and brain tumor cells [7]. In con-
trast, PD-L2 expression has only been reported in activated 
macrophages and dendritic cells [1,7]. To the best of our 
knowledge, the possibility of PD-L2 expression in nervous 
tissues outside the immune system has not been investigated. 
In this study, we used a commercially available an-
ti-mPD-L2 polyclonal antibody (pAb) (R&D Systems, MN, 
USA) to detect the distribution of mPD-L2 expression in 
non-immune tissues, including adult mouse brain and em-
bryonic tissues.  
1  Materials and methods 
1.1  Ethics statement 
C57BL/6 mice (SLAC, Shanghai, China) were housed in a 
specific pathogen-free environment at the animal facility of 
the Institute of Neurosciences, the Fourth Military Medical 
University. All procedures were conducted according to the 
guidelines approved by the Fourth Military Medical Uni-
versity Animal Care and Use Committee (permit number: 
082-2006). Mice were killed by decapitation or carbon di-
oxide asphyxiation, and all efforts were made to minimize 
suffering. 
1.2  Tissue preparation and staining 
(i) Fixation. Mice were anesthetized by intraperitoneal in-
jection of an overdose of 1% sodium pentobarbital. The 
mice were then fixed by perfusion with 4% paraformalde-
hyde (PFA) in phosphate-buffered saline (PBS) via the aor-
tic ventricle. The brain with intact olfactory bulbs and pitu-
itary were carefully dissected. The dissected tissues were 
immersed in 20% sucrose-PBS at 4°C until they sank to the 
bottom of the container. 
(ii) Decalcification. Adult mouse olfactory epithelium 
was prepared as described previously [8], with modifica-
tions. Briefly, after fixation, the head of the mouse was 
submersed in 10% EDTA until the bone became 
half-transparent and soft when tested by application of nee-
dle tracks. The decalcified brain was then placed in a 20% 
sucrose solution until the brain tissue was dense enough to 
sink to the bottom of the container.  
(iii) Immunohistochemistry (IHC). Tissue sections were 
cut at 10 m using a cryostat and mounted on poly-D-       
lysine-coated glass slides. The sections were incubated with 
the primary antibody diluted in 1% bovine serum albumin 
solution at 4°C overnight. After washing three times with 
PBS, the sections were incubated with fluorescein-conju-       
gated secondary antibody for 2 h at room temperature. The 
sections were observed and photographed under a BX51 
microscope (Olympus, Japan). Mouse embryos at embry-
onic days 10.5 (E10.5), E12.5, E14.5, E16.5, E18.5 and 
post-natal day (P) 1 were fixed with 4% PFA in PBS at 4°C 
overnight, soaked in 25% sucrose-PBS at 4°C overnight and 
embedded in Optimal Cutting Temperature compound. 
Frozen sections (10 μm thickness) were prepared as de-
scribed above. 
(iv) Whole-mount IHC (WMIHC) of embryos. E10.5– 
E12.5 embryos were fixed with freshly prepared metha-
nol/dimethylsulfoxide/H2O2 at 4°C for 5–10 h. Embryos 
were blocked with blocking reagents (PBSMT, 2% skim 
milk, 0.5% Triton X-100 in PBS) for 2 h with rocking and 
incubated with goat anti-PD-L2 pAb diluted in PBSMT at 
4°C overnight. Embryos were washed five times with rock-
ing in PBSMT for at least 1 h between washes, and then 
incubated with the biotinylated donkey anti-goat IgG anti-
body in PBSMT at 4°C overnight. The embryos were 
washed as before and incubated with avidin-biotin com-
plexes diluted in PBSMT at 4°C overnight. After washing, 
the embryos were incubated in diaminobenzidine/NiCl2 at 
room temperature for 30 min. H2O2 was added to a final 
concentration of 0.03% and rocked until the color intensity in 
the embryos appeared well-developed before background 
staining emerged. The results were photographed under a 
STZ10 stereomicroscope (Olympus). 
1.3  Antibodies 
Two lots of goat pAbs against mPD-L2 were purchased 
from R&D Systems (MN, USA). The catalog and lot num-
bers were AF1022, GVZ012091 and AF1022, GVZ016041, 
respectively. Rat monoclonal antibody (mAb) against 
mPD-L2 (clone: TY25) was purchased from eBioscience 
(CA, USA). Goat pAb against mPD-L1 was also purchased 
from R&D Systems (catalog number AF1019, lot number 
GGF016021). Rat anti-NCAM mAb was purchased from 
Abcam (UK). Fluorescein isothiocyanate (FITC)- and 
TexRed-conjugated donkey antibodies against goat IgG and 
FITC-conjugated goat antibody against rat IgG were pur-
chased from Jackson ImmunoResearch (PA, USA). Bioti-
nylated rabbit anti-rat IgG or anti-goat IgG and streptavidin 
horseradish peroxidase (HRP) were purchased from Sig-
ma-Aldrich (MO, USA). 
1.4  BLAST search and mRNA analysis by RT-PCR 
BLAST searches were performed within the National Cen-
ter for Biotechnology Information (NCBI) non-redundant 
database using the amino acid sequences of the mPD-L2 
extracellular domains, excluding the signal-peptide frag-
942 Zhao Y, et al.   Sci China Life Sci   November (2012) Vol.55 No.11 
ments. Candidate molecules, including butyrophilin-like 2 
(BTNL2), Skint1, hemicentin-1 and NCAM, which showed 
some degrees of identity with mPD-L2 by BLAST analysis, 
were subsequently chosen for detection in various tissues by 
PCR. 
Total RNA was prepared from organs including the ol-
factory bulb, olfactory membrane, pituitary, skin, tongue 
and brain, using the Rneasy Micro Kit (TaKaRa, Japan). 
Fixed amounts of RNA were reverse transcribed into cDNA 
with reverse transcriptase (TaKaRa). The following primers 
were used for PCR detection of PD-L2, BTNL2, Skint1 and 
hemicentin-1: PD-L2 forward, 5′-CTGAACTGGAAGGG- 
ATAAGAGC-3′ and reverse, 5′-GAAGATCAAAGCGAT- 
GGTGC-3′; BTNL2 forward, 5′-ATGGAGGACAGCACT- 
GAAGAGGG-3′ and reverse, 5′-TCCGAAGTTCTGGCA- 
TTGTGAAT-3′; Skint1 forward, 5′-TCCACCACAACAA- 
GCCCAGCAC-3′ and reverse, 5′-CGTGGGAACCAACC- 
TCCAGAGT-3′; hemicentin-1 forward, 5′-ATGATTGC- 
CCAGGAAGTGGTCC-3′ and reverse, 5′-TGGATAAGC- 
TGCAGCACCTCAT-3′. The PCR conditions consisted of 
35 cycles at 95°C for 30 s, 58°C for 30 s, and 72°C for 1 
min. PCR products were analyzed by agarose gel electro-
phoresis. 
1.5  Western blotting 
Crude olfactory bulb, head (without brain tissue), skin and 
brain (without olfactory bulbs) extracts were prepared using 
a Polytron homogenizer (FLUKO, Germany) in lysis buffer 
comprising 150 mmol L1 NaCl, 20 mmol L1 Tris-HCl (pH 
7.4), 5 mmol L1 EDTA, 1% NP40, and protease inhibitor 
cocktail (Complete™, Roche, UK), separated by SDS-     
PAGE, and transferred onto Hybond-P filters (Amersham 
Biosciences Co., NJ, USA). Filters were incubated with 
anti-mPD-L2 (1:100) and anti-NCAM (1:200) antibodies 
at 4°C overnight and visualized using an HRP-labeled an-
ti-mouse IgG Ab (CWbio, China) with the enhanced chem-
iluminescence system (Amersham Biosciences Co., NJ, 
USA). 
2  Results 
2.1  mPD-L2 pAb reacts with antigens in the olfactory 
epithelium, olfactory bulbs and pituitary gland 
Immunofluorescent staining of brain sections with anti-     
mPD-L2 pAb (catalog number AF1022, lot number 
GVZ012091) yielded unexpected results. The glomerular 
layers of the olfactory bulbs (Figure 1A and C) and acces-
sory olfactory bulbs (Figure 1B and C) were mPD-L2-       
positive. Meanwhile, the anti-mPD-L2 pAb stained the an-
terior (AP) and intermediate (IP) lobes, but not the posterior 
lobe, of the pituitary (Figure 1D). Most cells in the AP and 
IP gland were mPD-L2-positive. The ventral surface of the 
medium eminence was strongly mPD-L2-positive, extend- 
 
Figure 1  Immunostaining patterns of anti-mPD-L2 pAb in the adult 
olfactory system and pituitary gland. A, mPD-L2-positive signals in the 
glomerular layer of olfactory bulbs. B, mPD-L2-positive signals in acces-
sory olfactory bulbs (arrow heads) in the front sections of the brain. C, 
mPD-L2-positive signals in the glomerular layer of olfactory bulbs and 
accessory olfactory bulbs (arrow head) in a sagittal section. D, 
mPD-L2-positive signal distributions in anterior and intermediate pituitary 
(AP and IP) and the most ventral part of the pituitary stem (**) in a sagittal 
section (arrowheads). E, mPD-L2-positive signals in median eminence 
(EM). Strong fluorescence surrounded the EM (arrowheads) and densely 
positive nerve fibers were also seen in the bottom of the third ventricle 
(3V). The boxed area shows the enlarged mPD-L2-positive nerve fibers at 
the up-right corner of panel E. F, mPD-L2-positive signals in the olfactory 
epithelium. The boxed area shows the enlarged typical bipolar olfactory 
neurons at the upper-left corner of panel F. Scale bar, 50 m in A, B, C, D  
and 100 m in E, F. 
 
ing to the ventral medial hypothalamus. A group of mPD-        
L2-positive varicose terminal nerve fibers could be identi-
fied medial to the hypothalamic extension, which seemed to 
be converging towards the hypothalamic extension (Figure 
1E). mPD-L2-positive signals also extended onto the ventral 
surface of the pituitary stalk (Figure 1D). The presence of 
mPD-L2 in the accessory olfactory bulb and glomerular 
layer of the olfactory bulb suggested that the olfactory epi-
thelium, in which the olfactory primary sensory neurons are 
located, might also be mPD-L2-positive. Because the con-
voluted olfactory epithelium is located at the roof of the 
posterior nasal cavity, decalcified head tissue was used. 
mPD-L2-positive olfactory epithelium lining the nasal cav-
ity and typical bipolar olfactory sensory neurons in the ol-
factory epithelium could be identified (Figure 1F). However, 
we simultaneously stained the above-mentioned tissues with 
anti-mPD-L1 pAb and were unable to detect any mPD-L1 
signals (data not shown). These results demonstrated that 
mPD-L2-positive signals were distributed in the olfactory 
epithelium, olfactory bulbs and pituitary gland. 
2.2  Developmental characterization of mPD-L2 pAb 
cross-reactivity in mice 
We mapped the distribution of mPD-L2 in mice at different 
developmental stages, to help characterize the antigens that 
reacted with the anti-mPD-L2 pAb. Embryos at E10.5, 
E12.5, E14.5, E18.5 and neonatal mouse tissues at P1 were 
prepared, sectioned and incubated with anti-mPD-L2 pAb. 
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E10.5 and E12.5 embryos were also processed for WMIHC 
in situ.  
No detectable signals were found in WMIHC or IHC 
sections at E10.5 (Figure 2A). At E12.5, however, mPD-L2-       
positive olfactory nerve bundles from the nasal cavity pro-
jecting to the olfactory bulbs were clearly identified in both 
WMIHC and IHC sections (Figure 2BD). These nerve 
bundles targeted the outer layer of the olfactory bulbs, ap-
pearing as a curved shape in sagittal sections (Figure 2D). 
The epidermis of the mouth and nostrils was also mPD-L2-       
positive at this stage (Figure 2B and C). mPD-L2-positive 
signals along the oral cavity and tongue surface in WMIHC 
were confirmed by immunofluorescence staining in E12.5 
embryonic sections (Figure 2D). mPD-L2-positive signals 
began to appear in the olfactory epithelium, olfactory nerve 
bundles and olfactory bulbs at E12.5, and the epithelia of 
the oral cavity and tongue also displayed light mPD-L2-     
positive signals.  
mPD-L2-positive signals further increased at E14.5, and 
strong immunofluorescence signals were observed on the 
surfaces of the head, nasal and oral cavities (Figure 2E). 
The typical olfactory bipolar neurons in the olfactory epi-
thelium were strongly mPD-L2-immunoreactive. Bipolar 
cells extending dendrites to the epithelial surface from the  
 
 
Figure 2  Immunostaining patterns of mPD-L2 immunoreactivity at different developmental stages. A, No mPD-L2-positive signals were seen with 
WMIHC at E10.5. B and C, Side and front views of the embryonic head with WMIHC at E12.5. mPD-L2-positive signals were found in the olfactory bulbs 
(arrow head) and skin (arrow). D, Immunostaining in a sagittal section of E12.5 shows that the olfactory bulb and olfactory epithelium were 
mPD-L2-positive (box 1 and 2, respectively). The skin at the oral edge displayed mPD-L2-positive signals (arrow head). Boxed areas 1 and 2 are enlarged at 
the upper and bottom corners of the panel, respectively. E, Immunostaining in a head sagittal section of E14.5. The olfactory bulbs (arrow head), olfactory 
epithelium lining the top of the nasal cavity (**), epithelium lining the oral cavity (*) and skin (arrow) were mPD-L2-positive. F, Olfactory epithelium at 
E14.5 was mPD-L2-positive. Olfactory bulb (arrow head) and olfactory nerve bundles (arrow) showed strong immunostaining. The top boxed area shows an 
olfactory neuron with a typical bipolar shape. G, The primordium of the pituitary gland (dash-line circle), epithelia of oral cavity (*) and tongue (**) were 
mPD-L2-positive at E14.5. H, The epidermis (arrow) and hair follicles (arrow head) were mPD-L2-positive at E14.5. I, mPD-L2 immunostaining pattern of a 
frontal head section at E18.5. The epidermis, epithelia lining the oral (*) and nasal (**) cavities, epithelium of tongue (***) and vomeronasal sensory system 
(arrow head and boxed) were mPD-L2-positive. The boxed vomeronasal epithelium is enlarged at the corner of the panel. J, Immunostaining pattern of 
mPD-L2-positive signals in the pituitary at E18.5. Dashed lines separate the posterior pituitary (PP), intermediate pituitary (IP) and anterior pituitary (AP). 
mPD-L2-positive signals were present in the AP and IP but not in PP. K, The tongue epithelium was mPD-L2-positive at E18.5. The boxed area is enlarged 
at the corner of the panel. L, Whisker follicles (arrow heads) and epidermis (arrows) were mPD-L2-positive at E18.5. The boxed area is enlarged at the  
corner of the panel. 
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apical pole were characterized by the presence of dendritic 
knobs and numerous cilia (Figure 2F). The olfactory senso-
ry neuron axons fasciculated upon exiting the basal side of 
the olfactory epithelium and traversed the cribiform plate to 
form the outer layer of the olfactory bulbs (Figure 2F). In 
addition to the olfactory system, the primordial pituitary 
was beginning to display mPD-L2-positive staining at E14.5 
(Figure 3G). The oral and tongue epithelia displayed obvi-
ous mPD-L2-positive signals at E14.5 compared to their 
weak signals at E12.5. At this developmental stage, skin and 
hair follicles showed obvious mPD-L2-immunoreactivity 
(Figure 2H).  
At E18.5, the same staining pattern observed in the      
olfactory sensory neurons was also clearly present in the 
vomeronasal sensory neurons in coronal sections (Figure 2I). 
The mPD-L2-positive signal pattern was similar to that in 
the adult pituitary, in which the posterior pituitary (PP) was 
negative while the AP and IP contained numerous 
mPD-L2-positive cells (Figure 2J). Various epithelia in the 
head, including the skin, and epithelia of the tongue and oral 
cavity, displayed strong fluorescence signals at E18.5 (Fig-
ure 2K and L). Although epithelial cells surrounding the 
taste buds were positive, no detectable signals were found 
on the surfaces of the sensory cells in the taste buds. Fluo-
rescence signals were observed in the keratinized epithelial 
cells of the skin. In addition to its distribution in the skin, 
specific fluorescence was also detected in the hair follicles 
of the skin and whiskers (Figure 2L). Overall, these results 
demonstrated that mPD-L2-positive signals first appeared 
around E12.5 in the olfactory epithelium and olfactory 
bulbs, and then gradually extended to other epithelia in 
subsequent developmental stages. The distributions of 
mPD-L2 immunostaining patterns in tissues were similar 
from E14.5 to P1 until adulthood (data not shown). 
2.3  Cross-reactivity of anti-mPD-L2 pAb with anti-
gen(s) other than mPD-L2 
Some authors found no mPD-L2 mRNA in brain tissue by 
Northern blotting [8]. Given that the mPD-L2 molecule was 
reported to be distributed mainly in organs of the immune 
system, we suspected that the mPD-L2-positive staining in 
mouse brain and diverse epithelia might be due to 
cross-reactivity with proteins other than mPD-L2. To ex-
clude the possibility of differences in antibody quality be-
tween lots, we repeated the immunostaining experiments 
with a second batch of the pAb (R&D Systems; catalog 
number AF1022; lot number GVZ016041), and acquired 
similar results (data not shown). To further test our assump-
tion, we also purchased a mAb against mPD-L2 from eBio-
science, which has been used for IHC in other studies [5]. 
No positive signals in the adult brain or developing embryos 
were detected with this mAb (data not shown). RT-PCR 
also failed to detect any mPD-L2 mRNA transcripts in the 
brain, head, skin and tongue extracts of mice (data not 
shown). These results therefore confirmed that the an-
ti-mPD-L2 pAb from R&D Systems cross-reacted with an-
tigens other than mPD-L2 itself. 
To identify the proteins that could be targeted by the an-
ti-PD-L2 pAb, a BLAST database search was performed 
using the 20–241 amino acid sequence fragment of mPD-L2 
containing the extracellular domains, excluding its signal 
sequence. Several homologs of mPD-L2 with different se-
quence identities (Id) were found. Among these homologs, 
NCAM (Id about 30%), hemicentin-1 (Id about 27%), 
Skint1 (Id about 28%) and BTNL2 (Id about 28%) were 
chosen for further confirmation, based on their structures 
and identities.  
Western blotting showed that anti-NCAM could recog-
nize 180-, 140- and 120-kD bands in olfactory bulbs and 
brain tissue extracts, while only a 140-kD band was present 
in the skin and head (without brain tissue) extracts (Figure 
3A, left panel). The anti-PD-L2 pAb could also recognize 
proteins of around 180 kD, but not the 140- and 120-kD 
bands. In addition, the anti-PD-L2 pAb recognized several 
bands much larger than 180 kD (Figure 3A, right panel). 
However, no band appeared around 25 kD, which is the 
predicted molecular weight (MW) of mPD-L2 (data not 
shown). These results suggested that the anti-mPD-L2 pAb 




Figure 3  Western blot and RT-PCR analyses. A, Western blot analysis of extracts from the olfactory bulbs (ob), head (without brain tissue), skin and brain 
(without olfactory bulbs) with anti-NCAM mAb (left panel) and anti-mPD-L2 pAb (right panel). Left panel: 180-, 140- and 120-kD bands were recognized 
by the NCAM mAb in the brain and olfactory bulb extracts. However, the head and skin lanes only showed a definitive band around 140 kD and a weak 
120-kD band. Right panel: Using anti-mPD-L2 pAb, bands in addition to that around 180 kD appeared in all tissue lanes, with several bands much larger 
than 180 kD. B, RT-PCR detected Skint1, hemicentin-1 and BTNL2 transcripts from the olfactory bulb (ob), olfactory membrane (om), pituitary (pit), skin,  
tongue (ton) and brain tissue RNA extracts. 
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RT-PCR detected hemicentin-1 mRNA transcripts, but 
not Skint1 and BTNL2 transcripts, in the olfactory bulbs, 
olfactory epithelium, skin, tongue and brain tissue extracts 
(Figure 3B). These results suggested that NCAM and 
hemicentin-1 may be the novel antigens recognized by the 
anti-mPD-L2 pAb. 
2.4  Anti-mPD-L2 pAb and anti-NCAM mAb immu-
noreactivities co-localize within the olfactory system 
NCAM is one of the best-characterized members of the Ig 
superfamily. It is widely expressed in olfactory sensory 
neuron bodies and processes and plays important roles in 
the olfactory system. IHC analysis showed a high degree of 
overlap between the immunoreactivities of the anti-NCAM 
mAb and mPD-L2 pAb in the olfactory bulbs (Figure 4A, 
A′, A″), accessory olfactory bulbs (Figure 4B, B′, B″), ol-
factory sensory neurons (Figure 4C, C′, C″) and the vomer- 
 
 
Figure 4  Double-staining with anti-PD-L2 pAb (green) and anti-NCAM 
mAb (red) in sections of adult mouse tissues. A, Olfactory bulb. B, Acces-
sory olfactory bulbs. C, Olfactory epithelium. D, Vomeronasal sensory 
system. E, Epidermis and hair follicles. In the olfactory system, mPD-L2 
and NCAM signals were highly co-localized (yellow) except in epidermis  
and hair follicles. Scale bar, 100 m. 
onasal sensory neurons (Figure 4D, D′, D″). However, alt-
hough skin and hair follicles were positive for anti-mPD-L2 
pAb staining, they were negative for anti-NCAM mAb 
staining (Figure 4E, E′, E″).  
3  Discussion 
The two PD-1 ligands differ in their expression patterns, 
with PD-L2 expression being much more restricted than that 
of PD-L1 [9]. A variety of normal nonlymphoid tissues ex-
press PD-L2 transcripts, with high levels of expression in 
liver, low expression levels in the lung and kidney, and no 
expression in the brain [9,10]. However, transcript levels do 
not always correlate with protein levels [6,11]. In particular, 
PD-L2 protein is rarely detected in nonlymphoid organs 
under normal conditions because of post-transcriptional 
regulation [7]. PD-L2 is inducibly expressed in dendritic 
cells, macrophages and cultured bone marrow-derived mast 
cells [10]. In this study, the mPD-L2-positive signals dis-
tributed in nonlymphoid organs were thus highly suspected 
to result from cross-reaction with other antigens, based not 
only on previous studies, but also on the current results with 
mPD-L2 mAb in Western blot and RT-PCR experiments. 
Four proteins, BTNL2, Skint1, NCAM and hemicentin-1, 
were originally identified from the NCBI database based on 
a bioinformatic search for homologous proteins. These pro-
teins are all members of the Ig superfamily. BTNL2 is a 
butyrophilin family member with homology to B7 costimu-
latory molecules [12]. Analysis of BTNL2 in normal tissue 
showed that it is expressed in thymus, spleen, lymph node, 
stomach, small intestine, cecum, lung and large intestine 
[12]. Skint1 is a newly-identified gene expressed in thymus 
and skin that encodes a protein with an Ig-like domain, and 
which shows the greatest similarity to the butyrophilin gene. 
It encodes a protein of 364 amino acids with a predicted 
MW of 46 kD. RT-PCR of RNA from various tissues re-
vealed robust expression of Skint1 only in thymus and skin, 
and specifically in thymic epithelial cells and keratinocytes. 
Skint1 is expressed at E15 and continues into adulthood [13]. 
In this study, however, the characteristic expression patterns 
of BTNL2 and Skint1 differed from the mPD-L2 pAb im-
munoreactivity, and RT-PCR analysis also failed to detect 
BTNL2 and Skint1 transcripts in diverse epithelia and nerv-
ous tissues. These results suggest that BTNL2 and Skint1 do 
not cross-react with mPD-L2.  
Hemicentins are a family of secreted extracellular matrix 
components first identified in Caenorhabditis elegans, with 
two orthologs in most vertebrate genomes, including hu-
mans and mice [14]. Hemicentins are characterized by a 
single, highly conserved von Willebrand A domain at the 
amino terminus, a long stretch (>40) of tandem Ig domains, 
multiple tandem epidermal growth factor domains, and a    
single fibulin-like carboxyl-terminal module [14,15]. Hemi-
centin in C. elegans is composed of 5198 amino acids (>600 
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kD), and organizes hemidesmosome-mediated mechanosen-
sory neuron and uterine attachments to the epidermis. 
Hemicentin forms an oriented track-like geometry with the 
apparent function of constricting broad regions of cell con-
tact into discrete, linear junctions [14].  
In mouse developmental stages from E12.5, hemicen-
tin-1 expression can be observed in a pericellular pattern 
around individual epithelial cell surfaces. At E14.5, an-
ti-hemicentin-1 antibodies stain the periphery of basal and 
suprabasal keratinocytes and tongue epithelium, and by 
E17.5, hemicentin-1 staining is detected in hair and whisker 
follicles [16]. The characteristic expression pattern of 
hemicentin-1 during mouse development is very similar to 
that of mPD-L2. It therefore seems likely that hemicentin-1 
may cross-react with the anti-mPD-L2 pAb in mouse tis-
sues.  
The majority of cell adhesion molecules that have been 
identified in the nervous system fall into one of three fami-
lies based on their sequence structures: the Ig superfamily, 
the integrins, and the cadherins [17]. The Ig superfamily can 
be subdivided into at least five groups of related molecules 
based on the number of Ig-like domains, fibronectin type 
III-like repeats and the mode of membrane attachment: 
NCAM, L1, TAG-1, myelin-associated glycoprotein and P0 
[17]. Three major isoforms of NCAM are generated via 
alternative splicing of a primary transcript from a single 
gene. Two isoforms are transmembrane forms of 140 and 
180 kD, respectively, and the third (120 kD) is attached to 
the cell membrane via a glycophosphatidyl inositol linkage 
[18]. The amino acid sequences of NCAMs are highly con-
served among vertebrate species. 
During the embryonic and early postnatal development 
of the olfactory system in the mouse, NCAM was detectable 
in the developing olfactory epithelium, but not in regions 
developing into the respiratory epithelium [19]. Among the 
three isoforms of NCAM, NCAM-180 (isoform of 180 kD) 
is strongly expressed on neurons in the developing olfactory 
system. At E10.5, the upper medial portions of the nasal pit 
and axons leaving (from) the neural epithelium were 
NCAM-180-positive, and at E13.5, NCAM-180 was ex-
pressed in the cell bodies of sensory neurons and their den-
drites. Moreover, axons of the sensory neurons are strongly 
NCAM-180 immunoreactive in the nerve-fiber layer and in 
the glomeruli of the olfactory bulb [19]. This NCAM-180 
expression pattern in the olfactory system was similar to the 
anti-mPD-L2 pAb immunostaining pattern in the current 
study. The recognition of a band around 180 kD in olfactory 
bulb extracts by anti-mPD-L2 pAb in Western blots and the 
co-localization of mPD-L2-positive signals and NCAM 
immuoreactivities in olfactory bulbs and epithelia suggests 
that that anti-mPD-L2 pAb might cross-react with NCAM-      
180 in the olfactory system. 
Several reports have demonstrated the cross-reactivity of 
both mAbs and pAbs in IHC studies. mAb CD133-2 clone 
AC141 against hematopoietic stem cell antigen CD133 
showed cross-reactivity with cytokeratin 18 [20] in cryostat 
sections, but not in paraffin sections. The use of AC141 to 
identify CD133-expressing cells in cryostat sections could 
thus be misleading [20]. A commercial goat anti-mouse 
GATA-4 pAb (GMP) used to label Sertoli nuclei gave un-
expected results by labeling the complete development of 
the acrosome, from its assembly from fused Golgi vesicles 
to the lateral expansion of the acropaxome, which covers 
the spermatid nucleus [21]. These results were confirmed 
using a different batch of the commercial antibody. This 
fortuitous labeling of acrosome development with GMP 
antibody provides an alternative to the use of peanut and 
soybean agglutinin lectin histochemistry to label acrosomes 
[21]. This reflects the current study, where, although pAbs 
are well-known to cross-react with several epitopes and are 
prone to batch-to-batch variability, labeling of the develop-
ing olfactory epithelium with anti-PD-L2 pAb from R&D 
Systems was replicated with a different batch from the sup-
plier.  
In conclusion, our study showed that the anti-mPD-L2 
pAb tested here cross-reacts with several antigens in devel-
oping and adult mouse tissues. Care is therefore needed in 
interpreting the staining patterns obtained when the anti-     
PD-L2 pAb (R&D Systems) is used to identify PD-L2-     
expressing cells in the central nervous system and epithelial 
tissues, such as the olfactory epithelium. However, these 
results also indicate that this anti-PD-L2 pAb can be used as 
an alternative antibody for labeling the olfactory epithelium 
during embryonic development in mice. 
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